Skip to main content

previous disabled Page of 4
and
  1. No Access

    Article

    Trends in allogeneic hematopoietic cell transplantation survival using population-based descriptive epidemiology method: analysis of national transplant registry data

    Prognosis for patients undergoing hematopoietic cell transplantation (HCT) has been improving. Short-term survival information, such as crude survival rates that consider deaths immediately after the transplan...

    Yachiyo Kuwatsuka, Hidemi Ito, Ken Tabuchi, Takaaki Konuma in Bone Marrow Transplantation (2024)

  2. Article

    Open Access

    Cellular and humoral immunogenicity against SARS-CoV-2 vaccination or infection is associated with the memory phenotype of T- and B-lymphocytes in adult allogeneic hematopoietic cell transplant recipients

    We conducted a cross-sectional study to evaluate cellular and humoral immunogenicity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination or infection and examine how lymphocyte sub...

    Takaaki Konuma, Megumi Hamatani-Asakura in International Journal of Hematology (2024)

  3. Article

    Open Access

    Feasibility and safety of the discontinuation of systemic immunosuppressive treatment after single-unit cord blood transplantation in adults

    We retrospectively evaluated the incidence, factors, and clinical outcomes of the discontinuation of immunosuppressive treatment (IST) after single-unit unrelated cord blood transplantation (CBT) in adults rec...

    Takaaki Konuma, Maki Monna-Oiwa, Seiko Kato, Masamichi Isobe in Bone Marrow Transplantation (2024)

  4. No Access

    Article

    Donor NKG2D rs1049174 polymorphism predicts hematopoietic recovery and event-free survival after single-unit cord blood transplantation in adults

    Takaaki Konuma, Megumi Hamatani-Asakura, Maki Monna-Oiwa in Bone Marrow Transplantation (2024)

  5. No Access

    Article

    The effect of center experience on allogeneic hematopoietic cell transplantation outcomes in acute myeloid leukemia

    This study aimed to address the prognostic impact of center experience based on the data of 7821 adults with acute myeloid leukemia who underwent allogeneic hematopoietic cell transplantation (HCT) from 2010 t...

    Masamitsu Yanada, Shingo Yano, Yachiyo Kuwatsuka in Bone Marrow Transplantation (2024)

  6. No Access

    Article

    Allogeneic hematopoietic cell transplantation for patients with acute myeloid leukemia not in remission

    Allogeneic hematopoietic cell transplantation (HCT) is the last option for long-term survival for patients with chemotherapy-refractory acute myeloid leukemia (AML). By using the Japanese nationwide registry d...

    Masamitsu Yanada, Satoshi Yamasaki, Tadakazu Kondo, Takahito Kawata in Leukemia (2024)

  7. Article

    Open Access

    Low urinary sodium-to-potassium ratio in the early phase following single-unit cord blood transplantation is a predictive factor for poor non-relapse mortality in adults

    Although daily higher urinary sodium (Na) and potassium (K) excretion ratio is associated with the risk of cardiovascular disease in the general population, a low Na/K ratio is associated with renal dysfunctio...

    Kosuke Takano, Maki Monna-Oiwa, Masamichi Isobe, Seiko Kato in Scientific Reports (2024)

  8. Article

    Open Access

    Clinical implications of augmented renal clearance after unrelated single cord blood transplantation in adults

    Augmented renal clearance (ARC) is a phenomenon characterized by increased renal functionality, which can impact the pharmacokinetics and pharmacodynamics of antimicrobial drugs eliminated by the kidneys. It i...

    Takaaki Konuma, Kosuke Takano, Maki Monna-Oiwa in International Journal of Hematology (2023)

  9. No Access

    Article

    External validation and extended application of the transplant conditioning intensity score in acute myeloid leukemia

    This study aimed to validate the utility of the transplant conditioning intensity (TCI) score in 1714 patients with acute myeloid leukemia (AML) undergoing allogeneic bone marrow or peripheral blood stem cell ...

    Masamitsu Yanada, Yoshimitsu Shimomura, Shohei Mizuno in Bone Marrow Transplantation (2023)

  10. Article

    Open Access

    Should a matched sibling donor still be considered the primary option for allogeneic hematopoietic cell transplantation in patients over 50 years of age with myelodysplastic syndrome?

    Human leukocyte antigen (HLA)-matched sibling donors (MSDs) are the preferred choice for allogeneic hematopoietic cell transplantation (HCT). However, as myelodysplastic syndrome (MDS) is most frequently diagn...

    Takaaki Konuma, Hidehiro Itonaga, Ken Ishiyama, Noriko Doki in Bone Marrow Transplantation (2023)

  11. No Access

    Article

    Thyrotoxicosis after unrelated cord blood transplantation for adults

    Takaaki Konuma, Akira Tomonari, Jun Ooi, Hitomi Nagayama in Annals of Hematology (2023)

  12. No Access

    Article

    Age and allogeneic hematopoietic cell transplantation outcomes in acute myeloid leukemia

    Although several studies have reported significant effects of patient age on outcomes of allogeneic hematopoietic cell transplantation (HCT), the prognostic relevance of age must be determined separately for m...

    Masamitsu Yanada, Satoshi Yamasaki, Takaaki Konuma in International Journal of Hematology (2023)

  13. No Access

    Article

    Genetic deletion and pharmacologic inhibition of E3 ubiquitin ligase HOIP impairs the propagation of myeloid leukemia

    We investigated the role of Hoip, a catalytic subunit of linear ubiquitin chain assembly complex (LUBAC), in adult hematopoiesis and myeloid leukemia by using both conditional deletion of Hoip and small-molecule ...

    Koji Jimbo, Ayuna Hattori, Shuhei Koide, Takahiro Ito, Katsuhiro Sasaki in Leukemia (2023)

  14. No Access

    Article

    Salvage single-unit unrelated cord blood transplantation for graft failure following initial allogeneic transplantation in adult acute myeloid leukemia: trends in outcomes over the past 20 years

    Takaaki Konuma, Kaito Harada, Tadakazu Kondo in Bone Marrow Transplantation (2022)

  15. No Access

    Article

    Prognostic impact of switching from cyclosporine to corticosteroids early after single cord blood transplantation

    Kosuke Takano, Takaaki Konuma, Maki Monna-Oiwa, Masamichi Isobe in Annals of Hematology (2022)

  16. No Access

    Article

    Immunoglobulin superfamily member 8 maintains myeloid leukemia stem cells through inhibition of β-catenin degradation

    The identification of characteristic differences between cancer stem cells and their normal counterparts remains a key challenge for cancer treatment. Here, we investigated the role of immunoglobulin superfami...

    Koji Jimbo, Yaeko Nakajima-Takagi, Takahiro Ito, Shuhei Koide, Yasuhito Nannya in Leukemia (2022)

  17. Article

    Open Access

    Improved trends in survival and engraftment after single cord blood transplantation for adult acute myeloid leukemia

    Unrelated cord blood transplantation (CBT) is an alternative curative option for adult patients with acute myeloid leukemia (AML) who need allogeneic hematopoietic cell transplantation (HCT) but lack an HLA-ma...

    Takaaki Konuma, Shohei Mizuno, Tadakazu Kondo, Yasuyuki Arai in Blood Cancer Journal (2022)

  18. No Access

    Article

    Outcomes of third allogeneic hematopoietic stem cell transplantation in relapsed/refractory acute leukemia after a second transplantation

    Relapsed acute leukemia after allogeneic hematopoietic stem cell transplantation (allo-HSCT) is associated with poor prognosis. In a subset of patients, durable remissions can be achieved with a second allo-HS...

    Shinichi Kobayashi, Yoshinobu Kanda, Takaaki Konuma in Bone Marrow Transplantation (2022)

  19. No Access

    Article

    Long-term outcomes following the addition of granulocyte colony-stimulating factor-combined high-dose cytarabine to total body irradiation and cyclophosphamide conditioning in single-unit cord blood transplantation for myeloid malignancies

    An intensified myeloablative conditioning regimen, involving the addition of granulocyte colony-stimulating factor (G-CSF)-combined high-dose cytarabine (12 g/m2) to standard total body irradiation and cyclophosp...

    Takaaki Konuma, Jun Ooi, Hitomi Nagayama, Akira Tomonari in Annals of Hematology (2022)

  20. No Access

    Article

    The differential effect of disease status at allogeneic hematopoietic cell transplantation on outcomes in acute myeloid and lymphoblastic leukemia

    This study aimed to compare the effect of disease status at the time of allogeneic hematopoietic cell transplantation (HCT) on post-transplant outcomes between acute myeloid leukemia (AML) and acute lymphoblas...

    Masamitsu Yanada, Takaaki Konuma, Satoshi Yamasaki, Shohei Mizuno in Annals of Hematology (2021)

previous disabled Page of 4